|


Clinical aspects of TB
Pathology
and immunology
The host response
to infection by tubercle bacilli is primarily cellular: they are
phagocytosed by macrophages which are stimulated to produce enzymes
and cytokines. On average, the cell-medicated immunity develops
within 2-8 weeks after infection. These enzymes kill other tissue
cells and the cytokines promote the further infiltration of macrophages.
Granuloma
form and within a few days of infection, before the onset of acquired
immune response, the typical concentric tubercle has formed. This
limits local spread of infection and may achieve complete resolution.
The specific
acquired immune response is largely cell mediated. T-lymphocytes,
sensitised by contact with mycobacterial antigen, release lymphokines
which activate macrophages to kill tubercle bacilli and inhibit
intracellular multiplication. Such sensitised lymphocytes are induced
by BCG immunisation.
Local tissue
damage, characteristic of post-primary tuberculosis, is caused largely
by delayed hypersensitivity type reaction to mycobacterial protein
antigens. Delayed hypersensitivity is also cell-mediated involving
circulating sensitised T-lymphocytes and macrophages. It forms the
basis of the tuberculin test.
The function
of sensitised macrophages and lymphocytes is impaired when patients
are immunosuppressed (eg taking immunosuppressive drugs such as
corticosteroids, lymphoma, HIV infection) resulting in reduced host
defence.
|